To wrap up this year's author podcast series, The American Journal of Managed Care® speaks with Angela Liu, PhD, MPH, ...

Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...

CKD complicates cancer treatment, reducing adjuvant chemotherapy use and increasing mortality risk, necessitating ...

Soefje also discusses the growing role of pharmacists, technology, and comparative efficacy data in improving adherence, ...

Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers of progressive heart failure (HF) such as findings from echocardiogram ...

Highlights of the conference coverage from the 2025 European Society of Medical Oncology (ESMO) Congress included content on ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk ...

At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 ...

Sonrotoclax demonstrated a total overall response rate of 52%, including a complete response rate of 16%. However, Wang ...

Managed care organizations must prioritize dextromethorphan-bupropion based on sustained efficacy, improved remission rates, ...

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...